5 Best Quant Hedge Funds’ 5 Top Picks
Quantitative funds are gaining more ground among hedge funds in terms of trading volume and inflow of capital. According to The Wall Street Journal, this......(read more)
Posts Tagged ‘Amgen Inc (AMGN)’
15 Biggest Healthcare Companies in USA
If you’re seeking to invest in stocks with great long-term potential and are interested in adding some exposure to the healthcare sector, then the......(read more)
Here’s How This Week Has Started For The Financial Markets
1. U.S. Stock Market: “U.S. stocks rose on Monday, boosted by technology shares and by defense companies, which rose after the United States and......(read more)
How To Become A Successful Investor
How To Become A Successful Investor? Being a successful investor is difficult. The market can be very random and completely irrational much of the time......(read more)
Esperion Therapeutics Inc (ESPR): Get It While It’s Cheap
At the end of last week, Amgen, Inc. (NASDAQ:AMGN) announced some data from its large-scale trial of its cardiovascular risk asset Repatha. The drug first......(read more)
Amgen, Esperion, AmTrust Financial and More: What is Going On With These Falling Stocks?
Although all three major indexes have rebounded into the green this afternoon, shares of five companies, Amgen, Inc. (NASDAQ:AMGN), Esperion Therapeutics......(read more)
Sio Capital Remains Bullish On These Stocks Despite Weak Performance
As a healthcare-focused fund, Michael Castor‘s Sio Capital registered a terrible 2016, as it lost 18.7% net, compared to the 12% gain registered......(read more)
Why President Trump Wants To Transform The FDA – And What It Could Mean For Biotech Stocks
By Khojinur Usmonov From low costs to expedited drug approval, President Trump recently met with big pharma CEOs about overhauling the entire system.......(read more)
Regeneron Pharmaceuticals Inc (REGN) and Sanofi SA (ADR) (SNY) Obtain Suspension of Injunction for Cholesterol Drug Sales
Correction: A previous version of this article erroneously presented older events about the case between Sanofi/Regeneron and Amgen. The article has......(read more)
FDA Approves Amgen, Inc. (AMGN) Drug For Treating Secondary Hyperparathyroidism
Etelcalcetide, an Amgen, Inc. (NASDAQ:AMGN) drug that is meant to treat secondary hyperparathyroidism has been approved by the U.S. Food and Drug Administration......(read more)
What’s Next For Esperion Therapeutics Inc (ESPR)?
Esperion Therapeutics Inc (NASDAQ:ESPR) picked up strength at the end of last week, on the back of some news that – at first glance – seems unrelated......(read more)
Should Amgen, Inc. (AMGN) Be In Your Portfolio?
What does 2017 hold for Amgen, Inc. (NASDAQ:AMGN) and can this pharmaceutical stock lend color to your equity portfolio? Here’s a look at what makes......(read more)
Gilead Sciences, Inc. (GILD) Is A Hail Mary: 3 Better Stocks To Consider
After a strong 2015, health care stocks are leading the way lower in 2016. And it’s been an even uglier year for biotechnology company Gilead Sciences......(read more)
The Big Short’s Michael Burry Reveals His New Stock Picks
Michael Burry is one of the most well known hedge fund managers outside finance circles. Here is what we said about him in our previous article: “......(read more)
Highlights From Third Avenue’s Investor Letters
Third Avenue Management is a New York-based investment fund that uses a deep value investing strategy for stock selection. The fund was founded by Martin......(read more)
Why Wells Fargo, Gilead, Newfield, Amgen, and Chesapeake Energy Are Trending
All three indexes are in the green today after U.S. consumer confidence jumped to its highest figure in nine years during September. According to the......(read more)
Romosozumab From Amgen Inc (AMGN) Shows Positive Results In Osteoporosis
Romosozumab (AKA romo) from Amgen Inc (NASDAQ:AMGN) and Belgium-based UCB, which is in its Phase III FRAME study is yet to achieve any regulatory approval......(read more)
Coherus Biosciences Inc (CHRS) Has Set Its Sights On Amgen, Inc. (AMGN)
Coherus Biosciences Inc (NASDAQ:CHRS) submitted a biologics licensing application (BLA) for its lead biosimilar development candidate earlier this month......(read more)
Why ConocoPhillips, Amgen, Alere & Three Other Stocks Are Trending Today
Given that it’s the middle of earnings season, it’s not surprising that many major companies are trending today. The market are in the red......(read more)
Coherus Biosciences Inc (CHRS) Is Looking To Compete With Amgen, Inc. (AMGN)’s Cancer Blockbuster
The biosimilar space is relatively young. Only across the last handful of of years has the FDA put firm regulatory processes in place for the approval......(read more)
Glaxis Capital All-In on These Two Stocks After Slashing Portfolio
Paul Holland and Matthew Miller co-founded Glaxis Capital in 2005. The fund’s equity portfolio has remained fairly concentrated since the end of......(read more)
Can The Top 10 S&P 500 Dividend Growers Continue Their Rapid Dividend Growth?
The ten S&P 500 companies that have increased their dividend payout by the highest average annual rate during the last five years are analyzed in......(read more)
Marten Transport Ltd (MRTN), Amgen Inc. (AMGN) and Parker-Hannifin Corp (PH) Witness Striking Insider Selling
There are various reasons why corporate insiders might sell shares of their own companies. For instance, they may seek to diversify their holdings, buy......(read more)
Billionaire Dan Loeb’s Top Picks Register Disappointing Returns
Billionaire Daniel S. Loeb founded activist hedge fund Third Point LLC in 1995. The $17 billion New York-based firm lost 1.4% in 2015, which was not necessarily......(read more)
Hedge Funds Love These Biotech Stocks
Biotech has undoubtedly been one of the most cherished industries, among hedge funds over the last few years and it’s not hard to understand why......(read more)
Why Are Investors Piling Into These Five Stocks?
With crude futures failing to rally past a key technical resistance level, shares of Sunedison Inc (NYSE:SUNE), SolarCity Corp (NASDAQ:SCTY),Solaredge......(read more)
Billionaire Dan Loeb’s Top Picks For A Fourth Quarter Recovery
Billionaire activist investor Dan Loeb of Third Point saw his hedge fund post losses of 8.9% for the September quarter in comparison to the S&P 500......(read more)
Billionaire Dan Loeb Grows Bearish on the Market As Short Positions Outpace His Conviction Buys
Billionaire investor Dan Loeb, the founder of activist hedge fund Third Point LLC, discussed the performance of his investment firm, including the broader......(read more)
Sivik Global Healthcare’s Top Biotech Stock Picks For Q4
Sivik Global Healthcare is a Greenwich, Connecticut-based healthcare-focused hedge fund founded by Krishen Sud in 2006. In 2011, the fund merged with......(read more)
Billionaire Activist Dan Loeb Loses Money in Q3 but Remains Bullish on Stock Picks
When it comes to activist investing, Dan Loeb is one of the best in the business, generating strong returns through pushing companies to implement changes......(read more)
AbbVie, Biogen, Gilead: Smart Money Got Burned Betting on Biotech in Q3
When it rains, it pours, and for big pharma, it certainly poured in the third quarter. With the third quarter over, let’s take a closer look at ......(read more)
Five Best Stocks to Buy According To Quant Billionaires
One of the best ways to pick high-performing stocks is to follow the industry leaders and find out their stock investments. Today, we decided to cover......(read more)
Billionaire Dan Loeb Slightly Shuffles Third Point’s Top Picks, Selling Off Large Alibaba Group Holding Ltd (BABA) Stake
Famous billionaire activist hedge-fund manager Dan Loeb of Third Point is renowned for the bombshells that he drops on the management of his target companies......(read more)
United Therapeutics Corporation (UTHR), Amgen, Inc. (AMGN): Neil Shah’s Top Healthcare Picks Dominated S&P 500 Index in January-March
March Altus Capital Management, headquartered in Greenwich, Connecticut, was founded by Neil Shah in December 2011.This healthcare focused fund follows......(read more)
Ariad Pharmaceuticals, Inc. (ARIA), Amgen, Inc. (AMGN): How Sarissa Capital’s Top Picks Beat the Market
Headquartered in Connecticut, Sarissa Capital Management was founded by Alexander J. Denner in 2012. Prior to this, Mr. Denner worked as a portfolio manager......(read more)
Huge Losses in Alibaba Group Holding Ltd (BABA) Not Enough to Stop Billionaire Dan Loeb from Beating the Market
Considering that the second-largest holding of Dan Loeb‘s Third Point, Alibaba Group Holding Ltd (NYSE:BABA), lost 19.92% of its stock value during......(read more)
Healthcare Hedge Fund Orbimed’s Top Picks and New Move
According to a Schedule 13D form filed yesterday with the Securities and Exchange Commission, Samuel Islay‘s Orbimed Advisors has slashed its stake......(read more)
Gilead Sciences, Inc., Amgen, Inc., Biogen Idec Inc Among Billionaires’ 5 Hottest Biotech Picks
With the high volatility prevalent in the biotechnology sector, investors have a hard time picking the right stocks to invest in. Moreover, due to the......(read more)
Ariad Pharmaceuticals, Inc., Quest Diagnostics Inc, Amgen, Inc.: Sarissa Capital’s Top Stock Picks and New Moves
Alex Denner’s Sarissa Capital Management recently disclosed its stock picks for the fourth quarter of 2014 in a 13F Form filed with the U.S. Securities......(read more)
Billionaire Dan Loeb`s Third Point Looks to Rebound From Poor Year With Top Picks: Alibaba Group Holding Ltd (BABA), Amgen, Inc. (AMGN), Dow Chemical Co (DOW)
Dan Loeb`s Third Point filed its latest 13F with the SEC last week, detailing its long positions at the end of a self-admittedly poor year for the fund......(read more)
Apple Inc. (AAPL), Visa Inc (V), Actavis plc (ACT): Laurion Capital Reveals Top Stock Picks
Benjamin A. Smith’s Laurion Capital Management recently filed its 13F Form for last quarter with the U.S. Securities and Exchange Commission. Therein......(read more)
Epirus Biopharmaceuticals Inc (EPRS): These Two Funds Open New Positions
The days of having no fund activity in Epirus Biopharmaceuticals Inc (NASDAQ:EPRS) are over. In filings with the SEC that were revealed over the last......(read more)
Regeneron Pharmaceuticals Inc (REGN) Calls Game, Set and Match On Its Competitor: Jim Cramer
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) has, once again, shown today why biopharmaceuticals companies are so popular with investors, especially......(read more)
Amgen, Inc. (AMGN)’s Drug Trial Fails To Live Up To Expectation
Shares of Amgen, Inc. (NASDAQ:AMGN), which are up almost 16% this year, were trending high in the early afternoon hours, gaining nearly 4% after a day......(read more)
Amgen, Inc. (AMGN) Announces Revenue Growth And Profitability In The Second Quarter
Amgen, Inc. (NASDAQ:AMGN) announced its second quarter financial results on July 29, 2014. Amgen’s total revenues increased by 11% on the year......(read more)
Corinthian Colleges Inc. (COCO), FMC Corp (FMC): The Climb of the Dow and the IPO Tsunami Ahead – Bob Pisani
Commenting on the market movements, CNBC reporter Bob Pisani gave a brief on the latest trends in the market and the sectors which are on a high in the......(read more)
Stuart Weisbrod’s Iguana Healthcare Management Is Fond of These Stocks
New York City-based Iguana Healthcare Management was founded by Stuart Weisbrod in 2010. The fund invests in pharmaceuticals, biotechnology, medical devices......(read more)
Is PowerShare Buyback Achievers Fund a Buy? The Safest Way To Profit From $455 Billion In Stock Buybacks
Over the past few years at StreetAuthority, we’ve been chronicling the remarkable pace of share buybacks. So many companies are buying back $500......(read more)
Amgen, Inc. (AMGN)’s Potential Promise
Last Friday, Zacks released a new report were it reconfirmed its neutral rating for Amgen, Inc. (NASDAQ:AMGN). This company is the world’s largest independent......(read more)
Omthera Pharmaceuticals Inc (OMTH), Elan Corporation, plc (ADR) (ELN), Onyx Pharmaceuticals, Inc. (ONXX): 3 Big Biotech Buyouts of 2013
The Chinese calendar says 2013 is the year of the snake, but the market says it’s the year of biotech. Major biotechnology ETFs and indices have......(read more)
